Literature DB >> 32654702

Causes of Poor Medication Adherence in Sarcoidosis: Poor Patient-Doctor Communication and Suboptimal Drug Regimens.

Marc A Judson1.   

Abstract

Entities:  

Year:  2020        PMID: 32654702     DOI: 10.1016/j.chest.2020.03.001

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  1 in total

1.  Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis.

Authors:  William Damsky; Alice Wang; Daniel J Kim; Bryan D Young; Katelyn Singh; Michael J Murphy; Joseph Daccache; Abigale Clark; Ruveyda Ayasun; Changwan Ryu; Meaghan K McGeary; Ian D Odell; Ramesh Fazzone-Chettiar; Darko Pucar; Robert Homer; Mridu Gulati; Edward J Miller; Marcus Bosenberg; Richard A Flavell; Brett King
Journal:  Nat Commun       Date:  2022-06-06       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.